Imatinib Completed Phase 1 Trials for Chronic Myelogenous Leukemia (CML) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00047502Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia